Mirati Therapeutics
MRTX
$58.70
Share price
0.00%
Change (1 day)
29.75%
Change (1 year)
Categories
Mirati Therapeutics (MRTX) - Total debt
Total debt on the balance sheet as of September 2023 : $50.22 M
According to Mirati Therapeutics's latest financial reports the company's total debt is $50.22 M. A company’s total debt is the sum of all current and non-current debts.
Mirati Therapeutics - Total debt on balance sheet (from 2005 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $51.5 M | 9.07% |
| 2021-12-31 | $47.22 M | 12.68% |
| 2020-12-31 | $41.9 M | |
| 2019-12-31 | $N/A | |
| 2010-12-31 | $0.39 M | -28.75% |
| 2009-12-31 | $0.55 M | 13.28% |
| 2008-12-31 | $0.48 M | -32.27% |
| 2007-12-31 | $0.71 M | |
| 2005-12-31 | $0 M | -97.63% |
| 2004-12-31 | $0.23 M | -65.23% |
| 2003-12-31 | $0.68 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 TravelCenters of America TA | $2.16 B | 4,208.50% | 🇺🇸 USA |
 Nymox Pharmaceutical NYMX | $0.8 M | -98.40% | Bahamas |